List of the Top Healthcare AI Software for Small Business in 2026 - Page 8

Sentria stands out as an innovative platform that leverages artificial intelligence to oversee adverse event cases and facilitate post-marketing surveillance. This sophisticated software is not only user-friendly and highly customizable but also automated, ensuring compliance with industry regulations while enhancing the efficiency, speed, and accuracy of adverse event management. It effectively supports pharmacovigilance adherence to international ICH guidelines, along with local regulatory standards for adverse event evaluation. By offering an intuitive interface powered by pharmacovigilance automation, Sentria reduces reporting mistakes through intelligent alerts and streamlines the report processing by incorporating global coding standards such as MedDRA and ATC/WHO. Additionally, the platform significantly boosts analytical capabilities by implementing semantic artificial intelligence specifically designed for pharmacovigilance requirements. Among its key features are secure access regulated by user credentials, detailed auditable logs for compliance tracking, and a secure, encrypted cloud environment to safeguard data. Collectively, these features equip organizations with the tools to manage adverse events more efficiently, ultimately leading to improved patient safety outcomes. Moreover, Sentria's commitment to continuous improvement ensures that it remains at the forefront of pharmacovigilance technology, adapting to the evolving needs of the healthcare industry.

LifeSphere NavaX is your gateway to a future where advanced automation, artificial intelligence, and intelligent data analytics converge to revolutionize your business and enhance overall results. Designed with scalability and flexibility in mind, LifeSphere NavaX partners with you to define a customized automation journey that aligns with your unique goals, aspirations, and timelines. You retain control over the process, with the ability to activate or deactivate features as your requirements change over time. This innovative solution not only amplifies existing LifeSphere offerings but also integrates effortlessly with external systems, facilitating a smooth transition to a more intelligently automated landscape. Developed in collaboration with experts in the pharmaceutical and regulatory sectors, LifeSphere NavaX adheres to rigorous quality and security standards through thorough governance and compliance protocols. By automating tedious manual tasks and processes, it achieves substantial time and cost savings, potentially enhancing efficiency by up to 50% on vital workflows. Consequently, organizations can redirect their focus toward strategic priorities, resulting in improved productivity and sustainable growth. Moreover, the adaptability of LifeSphere NavaX ensures that it continues to meet the evolving needs of businesses in a rapidly changing environment.

See-Mode Technologies is a MedTech company dedicated to leveraging artificial intelligence to improve ultrasound reporting, thereby enhancing both the precision of diagnoses and the efficiency of operations. Their groundbreaking platform quickly analyzes ultrasound images related to the thyroid and breast, leading to swift and accurate radiology reports. By effectively identifying, measuring, and characterizing nodules, See-Mode generates a detailed TI-RADS sonographer worksheet along with preliminary assessments for radiologists. In the sphere of breast imaging, the application not only identifies lesions but also automates the BI-RADS reporting procedure, providing in-depth information regarding lesion characteristics and levels of suspicion. This sophisticated technology reduces variability between operators and diminishes the chances of reporting mistakes, which in turn boosts diagnostic confidence and ensures uniformity in results. By optimizing the reporting workflow, See-Mode empowers clinicians to make better-informed decisions, ultimately contributing to improved patient outcomes. This comprehensive approach marks a significant advancement in the field of medical imaging technology.

BrainSightAI stands at the forefront of health technology, leveraging artificial intelligence and machine learning to revolutionize the field of brain mapping via AI-driven connectomics, which facilitates the creation of customized brain maps. The VoxelBox product line utilizes these advanced AI methodologies to generate personalized brain maps, aimed at refining pre-surgical planning and enhancing outcomes for patients grappling with brain tumors and various neurological challenges. Additionally, BrainSightAI collaborates with leading hospitals nationwide to conduct clinical trials focused on a spectrum of brain-related ailments, including Alzheimer's disease, brain tumors, psychiatric disorders, Parkinson's disease, and stroke. Our primary mission is to advance brain science while enriching the lives of individuals through innovative tools that enhance our comprehension of the human brain. By working closely with healthcare professionals, we aspire to make a meaningful contribution to neurology and the overall quality of patient care, ultimately setting new standards in medical practice. Through our efforts, we hope to foster a brighter future for those affected by neurological conditions.

Fovia Ai's F.A.S.T. aiCockpit functions as an advanced AI viewer that improves the ease of navigation, visualization, and interaction with results generated by AI from different vendors and algorithms, all through a streamlined user experience that reduces the number of clicks required. This platform allows for the comprehensive visualization and engagement with algorithmic outcomes, presented in a single, intuitive interface that greatly benefits the workflow of radiologists and clinical specialists. By offering physician-validated insights to AI orchestrators, PACS, and reporting systems, it meets the latest interoperability standards in the industry. The system supports a variety of AI formats, including DICOM Structured Reports, DICOM Key Images, DICOM GSPS, and DICOM segmentation objects. Additionally, F.A.S.T. aiCockpit features a cloud-compatible architecture, which provides the ability to access AI-assisted radiology results from any location at any time using any web-enabled browser. With a single, simple integration, users can effortlessly enhance their AI capabilities without toggling between different viewers, thereby further optimizing their overall workflow. This forward-thinking solution not only boosts efficiency but also equips healthcare professionals to make quicker, more informed decisions, ultimately leading to improved patient care and outcomes. As a result, the integration of such advanced technology into medical practices signifies a transformative step for the future of healthcare.

HeartFlow provides a revolutionary non-invasive cardiac examination that produces intricate visual representations of each patient's coronary arteries, enabling healthcare professionals to formulate more personalized treatment plans. The procedure starts with a standard coronary computed tomography scan conducted at a healthcare facility. Once the scan is complete, the CT images are securely transmitted to our cloud-based system for analysis. Using advanced algorithms driven by artificial intelligence, a unique digital model of the patient's coronary arteries is created. Expert analysts meticulously examine this model, making necessary modifications to enhance its accuracy. After the personalized model is finalized, the HeartFlow pathway applies physiological principles and computational fluid dynamics to evaluate blood flow and determine FFRCT values throughout the entire structure. We maintain rigorous and well-defined protocols during this entire process to ensure consistent processing for each patient, which ultimately improves the quality of care delivered. This innovative methodology not only enhances diagnostic accuracy but also equips healthcare providers with the information needed to make informed choices for the best patient outcomes. Additionally, by leveraging such advanced technology, HeartFlow underscores its commitment to transforming cardiac care through precision medicine.

Established in 2016, Infervision is a leader in the realm of AI-powered medical technology, committed to improving healthcare operations and interdisciplinary services with cutting-edge artificial intelligence innovations. Their sophisticated AI solutions are crafted to support healthcare practitioners in a variety of functions, such as disease detection, diagnosis, intervention, treatment, patient management, and medical research. Notable among their products is InferRead CT Lung, which excels at identifying lung nodules in chest CT scans, while InferRead DR Chest is focused on uncovering chest abnormalities through X-ray imaging. Additionally, InferRead CT Coronary is specifically designed to detect coronary artery stenosis during coronary CT angiography, and InferRead CT Stroke is proficient in assessing brain hemorrhages via CT scans. The company also features InferRead CT Bone for identifying chest fractures in CT images, along with InferRead CT Pneumonia for diagnosing and managing pneumonia cases effectively. Their offerings extend further with InferOperate, which aids in 3D reconstruction for surgical procedures involving the thoracic, liver, and urological regions, as well as InferCare, a tool that enhances patient management and image follow-up. Furthermore, InferScholar serves as an AI-enhanced platform for advancing medical research, reinforcing Infervision's dedication to revolutionizing healthcare through its AI technology. This extensive collection of solutions firmly establishes Infervision as a crucial contributor to the advancement of modern medical practices, highlighting its role in shaping the future of healthcare delivery.

Qure.ai's qLC-Suite is an innovative AI-powered tool designed to enhance the early detection and management of lung nodules, which is vital for effective lung cancer treatment. This advanced solution provides precise measurements, detailed characterization, and three-dimensional imaging of lung nodules, ensuring that chances for early intervention are not missed. It adeptly supports both incidental and targeted screenings by swiftly identifying nodules and calculating their volume with a single click. Additionally, the system tracks volumetric changes over time, offering critical insights into the progression of nodules. The qLC-Suite is tailored to fit seamlessly into existing workflows, delivering rapid analysis and reporting that aid healthcare providers in their clinical decisions. Beyond its analytical functions, it acts as a comprehensive platform for lung nodule management, enhancing care coordination through smart prompts, allowing for hardware-independent image viewing of AI-optimized chest X-rays and CT scans, facilitating the easy sharing of images across various departments, and providing customized notifications for urgent cases. This platform not only streamlines the diagnostic process but also empowers healthcare teams to make informed decisions quickly. Altogether, the qLC-Suite represents a major leap forward in lung cancer management, encouraging timely medical interventions that can be life-saving for patients.

Us2.ai is transforming the fight against heart disease by leveraging AI-powered ultrasound software, making heart health services available to a broader audience. This groundbreaking platform offers 45 automated echo parameters, including strain analysis, and facilitates real-time interpretation of both 2D and Doppler images. It integrates effortlessly with any ultrasound machine, generating comprehensive reports without any user input, all while ensuring high accuracy that can be easily benchmarked against expert assessments. The AI echo copilot from Us2.ai independently evaluates all heart chambers using 2D and Doppler imaging, providing detailed, real-time reports that adhere to global reference guidelines. Recently, the software received FDA approval for Us2.v2, which continues to include the 45 automated echo parameters like strain analysis, marking a significant leap forward in healthcare innovation. Us2.ai aspires to democratize echocardiography, making ultrasound technology accessible to everyone, irrespective of their geographic or socioeconomic status, which is essential for enhancing heart health universally. This dedication to innovation and inclusivity places Us2.ai at the leading edge of the medical technology industry, promising a future where advanced heart care is within reach of all individuals.

Adonis is a cutting-edge platform that leverages artificial intelligence to revolutionize revenue cycle management by providing features for monitoring, alert notifications, and proactive resolution of issues. It enhances task prioritization for entities involved in revenue cycle management by delivering insights into trends concerning denials, underpayments, and key performance indicators. Through AI-driven analytics, Adonis aims to boost first-pass acceptance rates while minimizing human errors, going beyond just simple automation. The platform adopts a proactive stance towards denial prevention by automating routine tasks, allowing teams to focus more on patient care and improving the overall experience. Seamlessly integrating with existing electronic health records, practice management systems, billing solutions, and patient portals in real time, Adonis effectively eliminates data silos and encourages a cohesive workflow. Its solutions are tailored to accommodate a diverse array of healthcare organizations, such as hospitals, physician group practices, healthcare systems, digital health providers, and practice management services, ensuring each entity reaps the benefits of its customized offerings. This all-encompassing strategy not only optimizes operations but also cultivates a more effective and efficient healthcare environment, ultimately enhancing patient outcomes and satisfaction levels.

Ontosight Influence emerges as a powerful AI-driven platform that aids brands, marketers, and social media influencers in analyzing and enhancing their marketing strategies. Utilizing advanced analytics, it tracks and evaluates the performance of influencers alongside the overall effectiveness of various campaigns. By providing real-time insights into audience engagement, conversion rates, and return on investment, the platform enables businesses to make informed decisions and fine-tune their influencer marketing tactics. Its intuitive dashboard, customizable reporting features, and actionable insights streamline the decision-making process for users. Moreover, the platform harnesses machine learning to predict trends, identify key influencers, and recommend strategic partnerships. With specialized tools for content optimization, influencer discovery, and audience segmentation, it becomes an indispensable resource for executing data-informed influencer marketing campaigns, ultimately yielding improved outcomes for its clients. This extensive array of functionalities guarantees that brands remain competitive in the ever-evolving realm of digital marketing, allowing them to adapt swiftly to market changes and consumer preferences.

AIMedInfo is an advanced, AI-powered global medical information platform designed to enhance productivity and engagement within medical affairs through a comprehensive, integrated approach. This cutting-edge cloud-based solution utilizes sophisticated AI and machine learning techniques to efficiently manage medical information, ensuring swift and secure access to essential data while promoting continuous learning opportunities. With its robust multi-channel support system, AIMedInfo adeptly addresses inquiries from healthcare professionals (HCPs) and patients via AI-enhanced chatbots and live chat representatives available 24/7. Additionally, the platform seamlessly integrates data from standard response documents, prescribing information, and other resources, ensuring thorough and compliant assistance for medical inquiries. Moreover, AIMedInfo gathers critical insights and analytics on the behaviors of patients and HCPs, including the identification of potential adverse events, sentiment analysis, and monitoring of interaction frequency. This extensive functionality not only boosts the accuracy of responses but also significantly elevates the overall experience for all users involved, establishing AIMedInfo as an indispensable tool in the medical information landscape. As the platform continues to evolve, it promises to further refine its capabilities, adapting to the ever-changing needs of healthcare communication.

MedAffairs AI is a cloud-based machine learning solution designed to enhance the Medical Affairs domain within the pharmaceutical sector by utilizing advanced artificial intelligence. By tapping into a vast database of medical affairs knowledge, it provides users with swift and accurate responses to their questions, significantly reducing the time spent navigating through numerous drives and folders. This groundbreaking platform streamlines the integration of internal resources, such as clinical trial data, standard operating procedures, and relevant articles, allowing users to readily acquire information by querying their uploaded files. Each response is directly linked to the appropriate source document, making it easy to reference. In addition, MedAffairs AI facilitates searches across both internal and external datasets, delivering comprehensive insights into medical knowledge, adherence to regulations, interactions with key opinion leaders, and the development of medical strategies. By doing so, the tool not only conserves valuable time but also boosts the effectiveness of the Medical Affairs team in their strategic decision-making processes, ultimately contributing to better outcomes in the pharmaceutical landscape. This innovative approach signifies a notable advancement in how medical affairs teams operate, paving the way for improved collaboration and knowledge sharing.

ZAIDYN is an advanced, cloud-based solution developed by ZS, designed to revolutionize the life sciences industry. This pioneering platform integrates advanced analytics, machine learning functionalities, and intelligent workflows to assist organizations in optimizing their research and development, commercialization, and patient engagement processes. With its modular design, ZAIDYN provides adaptable solutions that can be tailored to fit a variety of needs, allowing for seamless integration with existing IT infrastructures due to its open architecture. By offering unified, high-quality data and actionable insights, the platform promotes improved collaboration among various departments, reducing operational silos and fostering more strategic decision-making. Emphasizing security and compliance, ZAIDYN ensures data privacy and adheres to regulatory requirements, positioning itself as a reliable choice for life sciences enterprises aiming to drive innovation and improve health outcomes. Its extensive capabilities empower organizations to effectively address the challenges of the industry, ultimately enhancing their overall operational efficiency and effectiveness. This makes ZAIDYN not just a tool, but a strategic partner in the pursuit of excellence within the life sciences domain.

ZS has developed Max.AI, a low-code/no-code platform that enables users to create autonomous AI agents on a large scale. Its architecture is cloud-agnostic, equipping users with enterprise-grade development tools and a range of pre-built use cases, which greatly enhances their ability to respond to diverse business needs. By integrating advanced large language models with traditional machine learning methods and unique datasets, Max.AI facilitates the rapid development and deployment of tailored generative AI solutions. Available through both AWS and Azure marketplaces, it ensures easy integration into existing client systems, thereby enhancing flexibility and scalability. Among its notable technological features are compatibility with hybrid cloud environments, a model-agnostic design, and a versatile software-defined analytics framework, all aimed at streamlining the creation and implementation of AI solutions across various industries. This platform is designed to make the utilization of AI capabilities more straightforward for organizations of any size and is positioned to drive innovation and efficiency in the rapidly evolving tech landscape. The ultimate goal of Max.AI is to democratize access to advanced AI tools, empowering users to leverage cutting-edge technology effortlessly.

Tempus AI, a leading health tech company located in Chicago, Illinois, is focused on revolutionizing patient care through the integration of advanced artificial intelligence and precision medicine. By harnessing data and AI, the firm aims to develop customized treatment strategies spanning various medical fields, including oncology, cardiology, radiology, and mental health. Their comprehensive platform merges genomic sequencing, clinical data, and AI-driven analytics, thereby providing healthcare professionals and researchers with vital insights. Tempus enhances patient understanding through a variety of testing methodologies, such as tissue and liquid biopsies, DNA and RNA sequencing, somatic and germline testing, as well as tumor-normal matched profiling and minimal residual disease monitoring. In addition, the company presents a fast and reliable platform for test ordering, acquiring patient insights, and integrating AI technologies into medical practice. Their innovative generative AI-enabled clinical assistant further streamlines access to patient insights, improving the efficiency of healthcare delivery. This dedication to leveraging state-of-the-art technology underscores Tempus AI's mission to elevate health outcomes and propel advancements in medical research. Ultimately, Tempus AI strives to be at the forefront of a transformative era in healthcare.

Microsoft's Dragon Copilot is an advanced AI-driven tool designed to improve clinical workflows by automating documentation, thereby reducing the burden of administrative tasks. By integrating smoothly with the Microsoft Cloud for Healthcare, it empowers healthcare practitioners to create accurate documentation based on their interactions with patients. This cutting-edge solution supports multiple languages and remains effective even without internet connectivity, allowing for the collection of patient data and its conversion into specialty-specific notes. Furthermore, Dragon Copilot leverages AI technology to suggest improvements for clinical interactions, automatically completes orders, and enables clinicians to search through notes to access medical information, ultimately boosting both the efficiency of operations and the standard of patient care. Its adaptability to the unique requirements of healthcare professionals positions Dragon Copilot to transform the management of clinical documentation significantly. As a result, healthcare providers can focus more on patient care rather than administrative duties, leading to better outcomes for both clinicians and patients alike.

Microsoft Cloud for Healthcare is a comprehensive platform designed to transform the healthcare landscape through the implementation of AI-driven solutions, data integration, and the promotion of secure, interconnected experiences. It supports healthcare providers, payors, and life sciences organizations in improving patient care, refining operations, and enhancing research initiatives. The platform offers tools that safeguard sensitive information, streamline clinical workflows, and promote increased patient engagement. By leveraging actionable insights from combined clinical and operational data, Microsoft Cloud for Healthcare enables healthcare organizations to realize better outcomes, increase efficiency, and reduce costs. Furthermore, this cutting-edge platform plays a crucial role in shaping the trajectory of healthcare delivery, driving innovation, and facilitating a more responsive healthcare ecosystem. In doing so, it paves the way for a future where healthcare is not only more effective but also more accessible to all.

Praxi is a cutting-edge data classification platform that utilizes artificial intelligence to transform unstructured data into valuable insights, particularly tailored for sectors with strict regulations such as healthcare, finance, and defense. By offering pre-trained AI models, it simplifies the data discovery, curation, and classification processes, greatly diminishing the necessity for manual effort and conserving both time and resources. The platform efficiently examines diverse data sources and silos, creating a unified interface that elucidates data relationships while adhering to GDPR regulations and enabling automated data curation. With the ability to provide real-time insights and bolster data governance, Praxi integrates effortlessly with existing systems, equipping organizations to maximize their data utilization, refine decision-making processes, and uphold compliance with regulations. Additionally, its intuitive design allows teams to concentrate on strategic projects while the platform adeptly handles the intricacies of data management, ultimately fostering a more efficient workflow. In doing so, Praxi not only enhances operational efficiency but also empowers organizations to achieve a competitive edge in their respective industries.

Interpret My Results is an intuitive web application designed for patients that leverages artificial intelligence to provide clear interpretations of lab results. By eliminating complicated medical jargon, it empowers users to better understand their health data, helping them bypass the wait for a doctor's appointment and the hassle of navigating ambiguous online information. This cutting-edge tool not only improves patient comprehension but also encourages active participation in health management, fostering a more informed approach to personal well-being. As a result, users can take charge of their health decisions with greater confidence.

PYCAD is a company dedicated to providing innovative artificial intelligence solutions specifically tailored for medical imaging and computer vision sectors. With over three years of specialized experience in medical imaging and six years in computer vision, PYCAD offers a comprehensive suite of services that includes data management, model training, and deployment. Their services begin with assisting clients in data preparation, which covers annotation support, anonymization, and format management, ensuring that the data is ready for thorough analysis and effective model training. PYCAD meticulously selects the most appropriate model configurations for various tasks and oversees the entire training process, leading to the development of high-performance models. Furthermore, the company deploys these optimized models as APIs on major cloud platforms like Google Cloud Platform (GCP) and Amazon Web Services (AWS), while also creating MVP user interfaces to facilitate seamless integration into clients' existing systems. Established in 2023, PYCAD has already completed more than ten projects, collaborating closely with clients to understand their needs and deliver impactful solutions. The company places a significant emphasis on data privacy and security, guaranteeing that all client information remains confidential and is permanently erased once projects are finalized. This steadfast commitment to customer satisfaction and data integrity fosters strong, enduring partnerships with their clients, further solidifying PYCAD's reputation in the industry. Additionally, the company's proactive approach to communication and feedback ensures that clients are consistently informed throughout each project phase.

Infinitus empowers healthcare businesses with FastTrack™, an AI-driven copilot that automates complex administrative tasks to maximize productivity. Whether it's skipping hold times or navigating through over 1,000 payor IVR systems, FastTrack™ ensures employees can complete more calls in less time without sacrificing service quality. With AI capabilities such as intelligent call initiation, auto IVR navigation, and parallel call processing, Infinitus significantly reduces employee burden and improves workflow efficiency. This enterprise-ready solution is purpose-built for healthcare tasks like claims, prior authorizations, and benefit verification. FastTrack™ integrates seamlessly with popular CRMs and EHRs and is HIPAA and SOC 2 Type 2 compliant, making it a trusted tool for Fortune 50 companies in the healthcare industry. Designed to scale with your business, Infinitus offers a secure, compliant, and powerful solution to help healthcare providers serve more patients without adding staff.

Infinitus offers a groundbreaking AI-powered solution designed to streamline healthcare workflows by automating calls with patients, payors, and providers. The platform’s AI agents can manage tasks such as benefit verification, prior authorizations, and prescription follow-ups, freeing up staff to focus on more critical patient care activities. With a proven track record of delivering 50% ROI and increased data accuracy, Infinitus helps healthcare organizations scale their operations without additional staffing. The platform uses advanced natural language processing and integrates with CRMs and EHRs, ensuring seamless workflow automation. Trusted by 44% of the Fortune 50, Infinitus is built to improve patient engagement, reduce operational costs, and increase efficiency in healthcare delivery.

MedGemma is a groundbreaking collection of Gemma 3 variants tailored specifically for superior analysis of medical texts and images. This tool equips developers with the means to swiftly create AI applications that are focused on healthcare solutions. At present, MedGemma features two unique variants: a multimodal version boasting 4 billion parameters and a text-only variant that has an impressive 27 billion parameters. The 4B model utilizes a SigLIP image encoder, which has been thoroughly pre-trained on a diverse set of anonymized medical data, including chest X-rays, dermatological visuals, ophthalmological images, and histopathological slides. Additionally, its language model is trained on a broad spectrum of medical datasets, encompassing radiological images and various pathology-related visuals. MedGemma 4B is available in both pre-trained formats, identified with the suffix -pt, and instruction-tuned variants, indicated by the suffix -it. For the majority of use cases, the instruction-tuned version is the preferred starting point, adding significant value for developers. This advancement not only enhances the capability of AI in the healthcare sector but also paves the way for new innovations in medical technology. Ultimately, MedGemma marks a transformative step forward in the application of artificial intelligence in medicine.

AuroraPrime represents a cutting-edge platform that utilizes generative AI to streamline the creation of content and documentation tailored for the life sciences industry. This innovative system automates the intricate process of producing detailed documents such as Clinical Study Reports (CSRs), study protocols, and safety narratives. Built on a flexible AI and LLM architecture, AuroraPrime effortlessly connects with existing enterprise systems to improve the entire product development lifecycle. Its notable features include AI-driven automation, which significantly speeds up the writing process by quickly generating accurate medical documents while requiring minimal human input, compliance verification that performs automatic evaluations against recognized standards to maintain precision and regulatory conformity, and a comprehensive content management system that catalogs all knowledge, templates, and documents for easy access and reuse. Furthermore, the platform boasts an intuitive interface that allows users with limited technical skills to efficiently navigate and fully leverage its extensive features. By simplifying complex documentation tasks, AuroraPrime empowers life sciences professionals to focus more on their core responsibilities and innovation.